International Journal of Stroke

Cover image for Vol. 9 Issue 6

Edited By: Geoffrey Donnan

Impact Factor: 2.748

ISI Journal Citation Reports © Ranking: 2012: 30/68 (Peripheral Vascular Disease)

Online ISSN: 1747-4949

Associated Title(s): World Stroke Academy



Author Guidelines


AUTHOR INSTRUCTIONS
International Journal of Stroke (Int J Stroke) (IJS)
Journal of the World Stroke Organization
https://twitter.com/IntJStroke
https://www.facebook.com/pages/International-Journal-of-Stroke

THE IJS TEAM

Editor-in-Chief
Geoffrey A. Donnan

Associate Editors
Peter Rothwell
Jong S. Kim
Patrick Lyden
Aryton Massaro
Michael Hill

Managing Editor
Carmen Lahiff-Jenkins

Production Editor
Maricris Adan

Impact Factor: 2.748
Peer-reviewed, Medline listed journal. We adhere as closely as possible to the COPE guidelines in all areas.

NIH Public Access Mandate .For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.

Author guidelines for the International Journal of Stroke are also available in the following languages: Chinese, Japanese , Spanish, Vietnamese – are currently in translation.

Photobucket


Author Guidelines
The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Acceptance rate
IJS has a 23% manuscript acceptance rate. We publish only eight editions plus a special World Stroke Day online edition, per year in 2014, so there can be a delay in publication times.

Background
The International Journal of Stroke (IJS) is the flagship publication of the World Stroke Organization, and concentrates on the clinical aspect of stroke with basic science contributions in areas of clinical interest, from the bench to home for the benefit of our readership. We are a small office, which means we are not in a position to turn papers around as quickly as our companions in medical publishing; however, we work hard to serve our authors well. We are committed to giving a global voice to authors; publishing with IJS puts authors and their work on an international stage.

Processing time
At some times of the year IJS processes can be mildly delayed due to travel absences of the Editor-in-Chief or Managing Editor. Please indicate your need for immediate processing so we can be as transparent, but proactive as possible.

COPE
IJS are signatories of the Committee on Publication Ethics (COPE) code of conduct for editors. We endorse the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement http://www.prisma-statement.org,
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097;
and Consolidated Standards of Reporting Trials (CONSORT) statement http://www.consort-statement.org.

Please contact our office at any time, we are pleased to assist you carmenl@unimelb.edu.au; (+61) [0] 3 90357017, and very keen for any feedback you may wish to offer about any of our processes.

SUBMISSION SEQUENCE
ScholarOne manuscripts (http://mc.manuscriptcentral.com/ijs)
• Covering letter
• Title page
• Text, including Abstracts, Introduction, Methods, Results, Discussion and Summary/Conclusions
• Acknowledgements
• Funding
• Conflict of interest
• References
• Tables
• Figures and figure legends
• Supplementary files for online only publication

REVIEW POLICY
IJS adheres to the COPE: CODE OF CONDUCT AND BEST PRACTICE GUIDELINES FOR JOURNAL EDITORS.
We do not review Leading opinions; Guidelines, unless otherwise advised or submitted without a statement of endorsement from a reputable society; Consensus unless otherwise advised or submitted without a statement of endorsement from a reputable society; and Panorama articles that are about the experience of the author, unless the experience cannot be validated. Letters-to-the-Editor are often articles that are of some interest to our readership and were found to be interesting, however did not meet all of the rigorous expectations of the reviewers the authors of these papers are often invited to publish as Letters-to-the-Editor. Peer review is an open review system because the stroke community is a small research pool. Because of this, IJS Editors take into consideration potential bias when making editorial decisions.

HOW TO SUBMIT YOUR PAPER USING SCHOLARONE MANUSCRIPTS
Once your manuscript is submitted to IJS it should not be under consideration by another journal.

Co-publication
IJS does engage in co-publication of some seminal works in the field, such as important guidelines etc. This must be negotiated with the Editor in Chief.

Using Scholar one/Manuscript central
All manuscripts should be submitted via the online submission and peer review website
ScholarOne manuscripts at http://mc.manuscriptcentral.com/ijs.
If you are new to ScholarOne please register first. This is the role of the corresponding author.
If you are registered to use Manuscript Central please log in and follow the onscreen prompts from the author dashboard.

FILE TYPE
It is recommended that text files be uploaded as Microsoft Word and figures as JPEG or TIFF. We encourage the inclusion of photographs, tables and figures, and submission of original and editable artwork. All digital photography files must be at least 300dpi.

COVER LETTER
You should upload your covering letter at the ‘Enter Comments’ stage of the online submission process. Use the covering letter to explain why your paper should be published in IJS. It can be helpful and expedite the reviewer process if you indicate the best possible uncompromised reviewers for your article for the assigned Associate Editor’s consideration.

TITLE PAGE
• Title • Author name(s) • Affiliation(s) • Address of all authors • three-seven key words • Word count • Itemized list of tables and figures.

Titles
• Titles may be edited or condensed at the Editors discretion.
• Please include a suggested ‘highlights’ or ‘cover’ title.

Authors
All names spelled out, initials only for middle names. Name, address and email of corresponding author separately entered.
• All authors, and all contributors (including medical writers and editors), should specify their individual contributions at the end of the text.
• IJS will not be able to publish any paper unless we have the signatures of all authors.
• We suggest you use the author statement form and upload the signed copy with your submission, on ScholarOne as a supplementary file for review.

Keywords
For use as indexing terms please provide six keywords, minimum.

Word count
Specify the number of words on your title page. Word count should include all parts of the manuscript (i.e., title page, abstract, main body of text, acknowledgments, sources of funding, disclosures, references, figure legends, tables, and appendices intended for print publication).

Itemized list of tables and figures
Please itemize all figures and tables.
Please indicate figures and tables in color – there is no cost for color figures. Help is available online or by e-mailing support@scholarone.com or carmenl@unimelb.edu.au.

Word limits

Manuscript type

Word limit

Abstract word limit

Figures and tables

References

Research

4,000

250 included in main word limit STRUCTURED

Included

Included

Review

5,000

250 included in main word limit

Included

Included

Systematic Review

5,000

250 included in main word limit STRUCTURED

Included

Included

Panorama

1,000

250 included in main word limit

Included

Included

Guidelines

2,000

250 included in main word limit

Included

Included

Protocol

2,000

250 included in main word limit STRUCTURED

Included

Included

Letters

300

No Abstract

Included

10 included

Leading Opinion

1,000

250 included in main word limit

Included

10 included

Short report

2,000

250 included in main word limit STRUCTURED

Included

20 included

SSO blog articles

1,000

No Abstract

Included

Included

Blog articles

800

No Abstract

Included

Included



Please include supplementary files separately, and clearly marked.

ABSTRACT
The abstract of your paper is the first point of contact between you and your readership. Your abstract must be excellent. We recommend you include in your abstract the number of centers and patients involved in your study. Please minimize the use of acronyms and abbreviations and make sure they are defined. Do not cite references in the abstract. Be concise (250 words maximum).

Structured Abstract (please review table above)
Systematic review
A Systematic review’s abstract should have the following headings:
• Background (description of reason for study)
• Aims
• Summary of review
• Conclusions (succinct statement of data interpretation)

Research paper and Short report
• Background (description of reason for study)
• Aims
• Methods (brief description of methods)
• Results (presentation of significant results)
• Conclusions (succinct statement of data interpretation)

Protocols
• Rationale
• Aim and/or hypothesis
• Sample size estimates
• Methods and design
• Study outcome(s)
• Discussion

PRESENTATION OF A REVIEW AND SYTEMATIC REVIEW ARTICLE
IJS no longer accepts reviews that have not been commissioned; however, please feel free to send a ‘pitch’ letter outlining a potential review to the Editor-in-Chief, Geoffrey Donnan (geoffrey.donnan@florey.edu.au), for consideration.

In accordance with PRISMA
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097
Reviews should be either definitive overviews of a major topic in neurology or an update of knowledge in a narrower field of current interest.

Complete transparency about the choice of material included is important; therefore, all reviews need to include a brief section entitled “Search strategy and selection criteria” stating the sources (including databases like PubMed, MeSH Searching Medicine etc. and free text search terms and filters, and reference lists from journals or books) of the material covered, and the criteria used to include or exclude studies. As these papers should be comprehensive, we encourage citation of publications in non-English languages.

PRESENTATION OF A LEADING OPINION ARTICLEthis article type is not reviewed
The aim of the Leading Opinion article is to produce rapid and fairly concise responses by world opinion leaders to recent developments in stroke in various parts of the world. Leading opinion articles are commissioned by the IJS Editors.

PRESENTATION OF A PANORAMA ARTICLE
- Panorama articles that are about the experience of the author, unless the experience cannot be validated
The objective of a Panorama article is to inform our international readership as to the different stroke activities in different countries and to introduce our readership to interesting and unique concepts of stroke. A Panorama article is rarely a single centre report, but more of an epidemiological study reporting, regional, state/province or national incidence.

PRESENTATION OF A CLINICAL TRIAL PROTOCOL ARTICLE
Manuscripts that incorporate clinical trial information, or subsequent reporting should be referenced against the CONSORT statement http://www.consort-statement.org/.

Please present your protocol as follows:
Abstract • Introduction and rationale • Methods • Design • Patient population - inclusion and exclusion criteria • Randomization • Treatment or intervention • Primary outcomes • Secondary outcomes • Data Monitoring Body • Sample size estimates • Statistical analyses • Study organization and funding •Discussion: This section is to contain the thoughts and rationale behind important points of study set-up • Summary and conclusions.

PRESENTATION OF A RESEARCH ARTICLE
All original articles incorporating clinical trial information and subsequent reporting, should be referenced against the CONSORT statement http://www.consort-statement.org/.
Please present your research paper as follows:
Abstract • Introduction • Aims and/or hypothesis • Methods • Results • Discussion • References.

PRESENTATION OF A GUIDELINES/CONSENSUS MANUSCRIPT
Guidelines are usually a condensed interpretation of a larger paper that goes through an extensive process, via a committee, and other interested parties. Please condense your manuscript to comply with our word limit but feel free to present the article in the committee/interested parties’ style. However, all manuscripts must provide a Statement of endorsement from a reputable society/societies.
Please also provide an abstract.

PRESENTATION OF LETTERS TO THE EDITOR
Letters to the Editor are published online only. They must begin with the salutation, ‘Dear Editor. Letters are often inadvertently reviewed, as they are often papers that didn’t quite make it to full publication, but are important to the stroke community. If a Letter is sent directly to the Editor relating to a paper, we will give the author of the mentioned paper, right of reply. RIGHT OF REPLY is 250 words.

ACKNOWLEDGEMENTS
We do not expect a signed letter for acknowledgements. However, we expect authors to utilize appropriate discretion and professionalism.

PERMISSIONS
Authors are responsible for obtaining permission to reproduce published (or otherwise copyright) material. A copy of the written permission(s) must be enclosed with the manuscript. Authors must also enclose a copy of the written consent of any person who can be identified in the text or illustrations. Please contact us if you need support with this process.

REFERENCES
• References must conform to the Vancouver style (http://en.wikipedia.org/wiki/Vancouver_system), should be numbered consecutively in the order in which they are first mentioned in the text.
• List all authors (include all initials) when there are six or fewer; when seven or more, list the first three and add 'et al'.

Standard journal
Give the title of the paper in full; the title of the journal abbreviated according to PubMed (if not listed then spell in full); the year; the volume number and the first and last page numbers of the article, e.g.:

Liapis CD, Michailidis D, Sivenius J et al. ESVS guidelines, Invasive treatment for carotid stenosis: indications-techniques. Eur J Vasc Endovasc Surg 2009; 37 (Suppl.):S1-19.

Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinant if ischemic stroke compared with coronary heart disease in women. Am Coll Cardiol 2006; 48:2235-42.

Section of a book
Liapis CD. Atherosclerosis risk factor treatment – general considerations; in Cronenwett JL, Johnston KW (eds): Rutherford’s Vascular Surgery, 7th edn. Philadelphia, W.B. Saunders, 2010.

Website
Please organize website reference as follows:
Author names (if any). Title of information or page. Name of website. URL. Publication date (if any). Access date. E.g.:

World Stroke Organization. Stroke, Cerebrovascular accident. WHO. 2013. Wednesday May 29, 2013.

Early View
International Journal of Stroke is now available via the Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue.

Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication.

OnlineOpen
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms .

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at https://onlinelibrary.wiley.com/onlineOpenOrder .

All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Author Services
Online production tracking is now available for articles through Wiley-Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they do not need to contact the Production Editor to check on progress.
Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more. Free access to the final PDF offprint of your article will be available via author services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.

SOCIAL MEDIA GUIDELINES
GUIDELINES FOR SSO BLOG MANUSCRIPTS
500 to 1000 words, one to two images, references allowed
The purpose of this blogging opportunity is to offer SSOs a space to connect with stroke practitioners and facilitate an information pathway to appropriate parties.

We request that SSOs address the following formatting requirements on presentation of their contribution to the International Journal of Stroke blog.
A simple text file with no formatting
A title page with the following information:

Title • Author name(s) All names spelled out initials only for middle names • Affiliation(s) • Address of all authors • Name, address and email of corresponding author to be clear • Provide approximately seven key words for use as indexing terms • Please provide word count • Please note any conflicts of interest; if there are none, please note this as ‘none declared’.

Authors and Author contacts – for publication as stipulated by authors.

Please provide links to Tweet and Facebook details, websites, YouTube/Vimeo channels etc.

CONFLICTS OF INTEREST
At the end of the text, under the subheading “Conflicts of interest”, all authors must disclose any financial and personal relationships with people or organizations that could inappropriately influence their work. Examples of financial conflicts include Author signatures, contributions, and declarations, employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within three years of beginning the work submitted. If there are no conflicts of interest, authors should use the phrase ‘The author/s declare no conflict/s of interest’.

DRUG NAMES
Drugs must be referred to generically; trade names may be included in parentheses.

ACRONYMS/ABBREVIATIONS
Please minimize the use of acronyms or abbreviations in the manuscript if they are used THEY MUST BE DEFINED.

EDITING
All manuscripts are subject to editing for length, clarity and conformity with International Journal of Stroke style all content must be approved by the Editor-in-Chief before being sent to graphics; any major content changes or cuts must be approved by the author.

PERMISSIONS
Authors are responsible for obtaining permission to reproduce published (or otherwise copyright) material. A copy of the written permission(s) must be enclosed with the manuscript. Authors must also enclose a copy of the written consent of any person who can be identified in the text or illustrations.

FIGURES AND ILLUSTRATIONS
Go to http://authorservices.wiley.com/bauthor/illustration.asp for author guidelines on electronic artwork. Tables must supplement the text without duplicating it. Each should be numbered, typed on a separate electronic sheet, and have an appropriate title, all manuscripts must be in basic Word format, PDF files cannot be accepted. Please do not create tables as a JPEG file if it can be avoided. They need to be in word format for editing purposes.

EXPEDITED PUBLICATION
The editors invite submission of manuscripts that have major importance to the scientific community. To be considered for expedited publication, an article must be unique and contain information that could make a significant difference in medical practice or constitute an important advance in basic knowledge. The authors must clearly state reasons for the request in the cover letter. If the editors agree that an article should be an expedited publication, they will arrange an accelerated review and, if accepted, accelerated publication.

COPYRIGHT FORM
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

Note to Contributors on Deposit of Accepted Version

Funder arrangements
Certain funders, including the NIH, members of the Research Councils UK (RCUK) and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website: http://www.wiley.com/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.

Institutions
Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the institutional repository after an embargo period. Details of such arrangements are set out at the following website: http://www.wiley.com/go/funderstatement

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit:http://www.wiley.com/go/funderstatement


PROCESS OF APPEAL

Contact us
Editor-in-Chief – Geoffrey Donnan - gdonnan@unimelb.edu.au
Assoc. Editor – Peter Rothwell - peter.rothwell@clinical-neurology.oxford.ac.uk
Assoc. Editor – Patrick D Lyden - Lydenp@cshs.org
Assoc. Editor – Michael Hill - hillmd@ucalgary.ca
Assoc. Editor – Jong S Kim - jongskim@amc.seoul.kr
Senior Assoc. Editor – Aryton Massaro - ayrton.massaro@gmail.com
Managing Ed – Carmen Lahiff-Jenkins – carmenl@unimelb.edu.au
Production Editor – Maricris Adan - ijs@wiley.com

Writing tips for authors
These golden rules may assist you with your manuscript.
• Write and edit to express yourself clearly.
• Avoid verbose language.
• Always write and edit your text so that everything can be understood and nothing misunderstood.
• Say what you mean to say, clearly and simply.
• Use short sentences.
• Avoid unnecessary acronyms and abbreviations.
• Use short paragraphs.
• Use the shortest, simplest words possible.
• Write in the active voice.
• Avoid unnecessary words.
• Use verbs for action.
• Avoid clichés and jargon.
• If in doubt, leave it out.

SEARCH

SEARCH BY CITATION